Dallas Sinus Center is categorized under Medical Centers in Dallas, TX and active since 2011.
Dallas Sinus Center was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 621112 by the NAICS.
If you are seeking more information, feel free to contact N Emery- Machado at the company’s single location by writing to 11970 North Cntl Expressway # 670, Dallas, Texas TX 75243 or by phoning (214) 382-5100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dallas Sinus Center |
| Contact Person: | N Emery- Machado |
| Address: | 11970 North Cntl Expressway # 670, Dallas, Texas 75243 |
| Phone Number: | (214) 382-5100 |
| Website Address: | dallassinuscenter.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 621112 |
| Share This Business: |
Dallas Sinus Center was started in 2011 to provide professional Medical Centers under the SIC code 8011 and NAICS code 621112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact N Emery- Machado for inquiries that concern Dallas Sinus Center by calling the company number (214) 382-5100, as your correspondence is most welcome. Additionally, the physical location of the single location of Dallas Sinus Center can be found at the coordinates 32.912295,-96.767959 as well as the street address 11970 North Cntl Expressway # 670 in Dallas, Texas 75243.
For its online presence, you may visit Dallas Sinus Center’s website at dallassinuscenter.com and engage with its social media outlets through on Twitter and on Facebook.